According to Avadel Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.0. At the end of 2024 the company had a P/S ratio of 8.88.
Year | P/S ratio | Change |
---|---|---|
2024 | 8.88 | -80.41% |
2023 | 45.3 | |
2022 | N/A | |
2021 | N/A | -100% |
2020 | 17.4 | 265.01% |
2019 | 4.77 | 416.39% |
2018 | 0.9247 | -50.87% |
2017 | 1.88 | -34.01% |
2016 | 2.85 | -2.58% |
2015 | 2.93 | -97.27% |
2014 | 107 | 1068.4% |
2013 | 9.19 | 217.03% |
2012 | 2.90 | -27.36% |
2011 | 3.99 | -12.22% |
2010 | 4.54 | 6.26% |
2009 | 4.28 | 74.07% |
2008 | 2.46 | -62.48% |
2007 | 6.55 | -79.02% |
2006 | 31.2 | 64.56% |
2005 | 19.0 | 207.62% |
2004 | 6.17 | -73.32% |
2003 | 23.1 | 502.17% |
2002 | 3.84 | 13.99% |
2001 | 3.37 |